Both Wegovy and Ozempic contain semaglutide but differ in FDA indication and dosing. Wegovy (up to 2.4mg/week) is approved for weight loss while Ozempic (up to 2mg/week) is approved for type 2 diabetes. Off-label Ozempic use for weight loss is common but controversial. Insurance coverage differs significantly. Learn more about Semaglutide | Start assessment. Source: FDA